Coreline Soft and Mint Medical Partner for AI-Enabled Lung Cancer Screening
Coreline Soft and Mint Medical have formed a partnership focused on advancing AI-enabled lung cancer screening. Their collaboration integrates Coreline Soft’s AI imaging platform AVIEW into Mint Medical’s mint Lesion platform, enhancing workflows for pulmonary nodule detection and structured reporting. Initially targeting Germany, where lung cancer screenings are being reimbursed, the partnership aims to scale internationally. This integration is designed to improve clinical workflows, ensuring quality assurance and compliance with national screening standards. Coreline Soft’s AI has been utilized in over 2.5 million clinical reads in various countries.
HEIDELBERG, Germany and SEOUL, South Korea, June 18, 2026 /PRNewswire/ — Coreline Soft and Mint Medical today announced a partnership to advance AI-enabled lung cancer screening, following more than six months of technical collaboration and integration work. Through this collaboration,…